Showing results (1751-1760 of 3,339) with videos related to

Sort By:
Pageof 334
Biomacromolecules|November 10, 2020
Modular Genetic Code Expansion Platform and PISA Yield Well-Defined Protein-Polymer AssembliesDominic J Rucco, Brooke E Barnes, John B Garrison, et al.
The Journal of Reproductive Medicine|October 28, 2017
Fetal Growth Outcomes in a Cohort of Polydrug- and Opioid-Dependent PatientsLaura Garrison, Lawrence Leeman, Renate D Savich, et al.
British Journal of Clinical Pharmacology|October 21, 2022
Factors relating to nonpublication and publication bias in clinical trials in Canada: A qualitative interview studyRichard L Morrow, Barbara Mintzes, Garry Gray, et al.
IEEE Transactions on Cybernetics|April 17, 2019
End-to-End Incomplete Time-Series Modeling From Linear Memory of Latent VariablesQianli Ma, Sen Li, Lifeng Shen, et al.
Physical Therapy in Sport : Official Journal of the Association of Chartered Physiotherapists in Sports Medicine|June 4, 2019
The validity and reliability of the Vail Sport Test™ as a measure of performance following anterior cruciate ligament reconstructionJoseph Hannon, Sharon Wang-Price, Chad Swank, et al.
Scientific Reports|April 16, 2021
Cetacean distribution models based on visual and passive acoustic dataKaitlin E Frasier, Lance P Garrison, Melissa S Soldevilla, et al.
The American Surgeon|July 4, 2012
Intestinal microcirculatory flow alterations in necrotizing enterocolitis are improved by direct peritoneal resuscitationAlexandra C Maki, Paul J Matheson, Jessica A Shepherd, et al.
Contemporary Clinical Trials|September 18, 2012
The value of comparative effectiveness research: projected return on investment of the RxPONDER trial (SWOG S1007)William B Wong, Scott D Ramsey, William E Barlow, et al.
Psychology of Addictive Behaviors : Journal of the Society of Psychologists in Addictive Behaviors|May 11, 2023
Alcohol and common ground: The effects of intoxication on linguistic markers of shared understanding during social exchangeAnna C S Garrison, Si On Yoon, Sarah Brown-Schmidt, et al.
Journal of Medical Economics|October 13, 2012
Ipilimumab in 2nd line treatment of patients with advanced melanoma: a cost-effectiveness analysisVictor Barzey, Michael B Atkins, Louis P Garrison, et al.
Pageof 334